GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Natco Pharma Ltd

Natco Pharma Ltd Board Meeting to Consider Q1 FY27 Unaudited Results & Interim Dividend

RESULTS ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 06 Aug 2026, 04:50 PM IST  ·  BSE ID: d19af757-2c0a-43d2-a451-cf3c962e44db
View Original BSE Filing (PDF)
💡
In Simple Terms
Natco Pharma's board will meet on August 14, 2026, to discuss its latest quarterly earnings and a potential interim dividend.
🤖 AI Summary
  • Natco Pharma Ltd Board of Directors to convene on August 14, 2026.
  • Meeting agenda includes considering Unaudited Financial Results for quarter ended June 30, 2026.
  • Board will also deliberate on an interim dividend for the financial year 2026-27.
  • Trading window for company securities closed from August 7, 2026, to August 16, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this notice.
👤
Who Is Affected
Shareholders will be affected by the decisions made at the Board Meeting, specifically regarding quarterly financial performance and any declared interim dividend.
🔍
Management Signal
Management is adhering to regulatory timelines for financial reporting and dividend consideration.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Natco Pharma Ltd Board Meeting outcome on August 14, 2026.
Announcement of Unaudited Financial Results for Q1 FY27.
Details of any interim dividend declared for FY2026-27.
LOW RISK This is a routine procedural announcement for a board meeting.
💡 Investor Takeaway
Natco Pharma Ltd has scheduled a Board Meeting for August 14, 2026, to consider its Unaudited Financial Results for the quarter ended June 30, 2026. The Board will also review an interim dividend for the financial year 2026-27.
❓ Frequently Asked Questions
When is the Board Meeting for Natco Pharma Ltd scheduled?
The meeting of the Board of Directors of Natco Pharma Ltd is scheduled for Friday, August 14, 2026.
What financial results will the Natco Pharma Board consider?
The Board will consider the Unaudited Financial Results for the quarter ended June 30, 2026.
Will Natco Pharma Ltd consider a dividend at this meeting?
Yes, the Board will consider an interim dividend, if any, for the financial Year ending 2026-27.
When is the trading window closed for Natco Pharma Ltd securities?
The trading window is closed from August 7, 2026, to August 16, 2026 (both days inclusive).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.